Reddit Posts
This is your friendly reminder that it is time to take a look at US cannabis ETF $MSOS. Rescheduling of cannabis is imminent. It’s the perfect entry.
Gillibrand, Nadler call on AG Garland, DEA to scrap federal laws targeting weed
Gillibrand, Nadler call on AG Garland, DEA to scrap federal laws targeting weed
3 promising small-cap stocks you should consider adding to your watch list
3 promising penny stocks you should consider adding to your watchlist
3 promising penny stocks you should consider adding to your watchlist
US MSO Stocks Steadily Rising In Anticipation of Rescheduling
The weed sector is for bag holders and morons, they said. Don't waste your time, they said.
Best single trade yet (CRWD leap) and Goog calls. But wait theres more! Weed's being rescheduled bois (in with ~50k) $MSOX
“Historic Shift - Cannabis Rescheduling Possibility Explained”
DEA Considers Rescheduling Cannabis: What This Means For U.S. And Global Policy
Matt Zorn: The Lawyer Who Beat The DEA (Explained) | TDR Exclusive
Rescheduling and Near Term Catalysts for US Multi-State Operators
$HITI , the most undervalued company in its sector and the best performing
$HITI , the most undervalued company in its sector and the best performing
$HITI , the most undervalued company in its sector and the best performing
A huge trading opportunity could be coming if the Biden administration reforms marijuana laws
DEA Considers Rescheduling Cannabis—What This Means For U.S. And Global Reform
Podcast: Boris Jordan to Start Roadshow on Jan 23 to meet Institutional Investors
DEA is Going to Have a Hard Time Fighting Marijuana Rescheduling
Cannabis Bull Market Scenario Analysis with PS Ratio Valuation
Cannabis Stocks: Squeeze to the moon when DEA reschedules THC...
Top Biden Health Official In Touch With DEA About Marijuana Rescheduling Recommendation
HHS Strong Rescheduling Recommendation and Impact on MSOs Lawsuit Against DOJ
$MSOS DD: Squeeze Potential + Analysis
Top Biden Health Official In Touch With DEA About Marijuana Rescheduling Recommendation
HHS Strongly Recommends Schedule to III
$TLRY $MSOS BREAKING: Feds Release Marijuana Documents, Confirming Schedule III Recommendation Based On ‘Accepted Medical Use’
12 State Attorneys General Tell DEA To Reschedule Marijuana As ‘Public Safety Imperative’
$MSOS $TLRY BREAKING: Feds Will Release Marijuana Rescheduling Memo And Related Documents ‘In Their Entirety’ In Response To Lawsuit
Trump's lead (40%) is growing over Biden (37%). The Biden administration needs to make the DEA Cannabis Schedule 3 announcement sooner rather than later due to the full process.
What will happen to cannabis stocks in 2024?
Republican Steven Cohen - "#Cannabis shouldn't be a Schedule 1 drug—more like Schedule 420. I've pressed the DEA on this for years (most recently in July, QT'd 👇) & I'm weighing back in today. Full letter here:"
MSOS TLRY "Congressman Tells DEA To Reschedule Marijuana ‘As Swiftly As Possible’"
Congressman Tells DEA To Reschedule Marijuana ‘As Swiftly As Possible’
Congressman Tells DEA To Reschedule Marijuana ‘As Swiftly As Possible’
Higher Exchanges: 2024 Cannabis Investing Preview
MSOS halted today on news that DEA reviewing Marijuana classification
DEA Tells Congress It Has ‘Final Authority’ On Marijuana, Regardless Of Health Agency’s Schedule III Recommendation
The Drug Enforcement Administration (DEA) letter obtained by punchbowl.
DEA tells House lawmakers marijuana review is ongoing #MSOS #MSOX
DEA tells House lawmakers marijuana review is ongoing
DEA reviewing marijuana's classification, per Punchbowl
DEA Calls For Even More THC, Psilocybin And DMT To Be Produced For Research In 2024
DEA calls for higher quotas of cannabis for schedule 1 research.
Why fears about Biden’s marijuana moves are overblown
Tesla Investor Ross Gerber Calls On DEA To Reschedule Cannabis: 'Absurd We're Still Waiting'
This is an obvious bet right? Why isn't everyone doing it? Am I crazy?
Independent pharmacies receiving threatening letters from DEA about selling medical marijuana
HHS official calls for reclassifying marijuana as a lower-risk drug in letter sent to DEA
Is this recent run due to anything more than a lot of confident speculation on DEA Schedule 3?
$MIRA trading at $3.80 - valuation of $22.70 based on DCF analysis
$MIRA trading at $3.80 - valuation of $22.70 based on DCF analysis
Beacon Analyst update on Re-Schedule and SAFER
Cannabis & Schedule III - Next Steps for the DEA — Insights X MSO-MAO
High Tide HITI looks extremely bullish!
Senator Pushes DEA To Act With 'Great Urgency' To Reschedule Marijuana
Long $MSOS (USA Cannabis ETF) - Senator Pushes DEA To Act With ‘Great Urgency’ To Reschedule Marijuana 🚀🌕📈
Kim Rivers BNN Bloomberg interview Nov 9th @ 5:25 mark - "We are waiting any day now for DOJ/DEA to affirm HHS"
$MSOS USA Cannabis ETF - January 2024 bullish call spread bet for DEA (Drug Enforcement Agency) accepting rescheduling to class 3 🌿🔥😎
DEA likely to OK marijuana rescheduling, but election and lawsuits could get in the way
Former FDA Official Predicts DEA Will Reschedule Cannabis by Next Presidential Election
Former FDA Official Says He’d Be ‘Shocked’ If DEA Doesn’t Reschedule Marijuana By 2024 Election
Former FDA Official Says He’d Be ‘Shocked’ If DEA Doesn’t Reschedule Marijuana By 2024 Election
DEA likely to approve marijuana rescheduling recommendation
Bipartisan House Coalition Urges DEA to Align with Federal and State Cannabis Reforms
How long do you expect the DEA's rescheduling to take?
Federal Appeals Court Rules Against DEA In Psilocybin Rescheduling Lawsuit Brought By Doctor Who Wants To Give Psychedelic To Cancer Patients - Marijuana Moment
31 Bipartisan House Lawmakers Push DEA To Consider ‘Merits’ Of Marijuana Legalization As It Completes Scheduling Review
Here's the question, It's getting more,Top Federal Health Agency Releases Highly Redacted Marijuana Scheduling Recommendation Letter To DEA
Top Federal Health Agency Releases Highly Redacted Marijuana Scheduling Recommendation Letter To DEA
Former DEA heads oppose cannabis rescheduling
Marijuana Rescheduling Would ‘Supersize’ The Industry, Former DEA Heads And White House Drug Czars Warn Biden Administration
Endexx Provides Insight on Possible New Federal Cannabis Regulations
Special Briefing on Cannabis Federal Scheduling Reform (Vicente)
[Webinar] Special Briefing on Cannabis Federal Scheduling Reform
4 years ago Patrick McHenry opposed the SAFE Banking Act. But that changes (maybe) if there is a down-scheduling of marijuana from 1 to 3.
90 day DEA response to HHS and when it becomes law with source
When must the DEA legally have an answer on descheduling?
American Council of Cannabis Medicine Prepares DEA Rescheduling Application; Backs HHS Directive on Cannabis Rescheduling Industry Input Opens This Week
Mentions
It's funny, because about two to three weeks ago he was saying that he wasn't thinking of days or weeks about the timing of S3 final rule. He believes that the final rule will drop before the CBD program goes live in April. I can see the reasoning why, but I remain skeptical of the DOJ's and DEA's competence to pull it off before that deadline. Also, the CBD in that program is not derived of THC at all, so S3 barely has any relation at all to it.
Perhaps a review of DEA's scheduling definitions will clarify what rescheduling marijuana from 1 to 3 means: **Schedule I** Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote. **Schedule II** Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Some examples of Schedule II drugs are: combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin **Schedule III** Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are: products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone **Schedule IV** Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol **Schedule V** Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes. Some examples of Schedule V drugs are: cough preparations with less than 200 milligrams of codeine or per 100 milliliters (Robitussin AC), Lomotil, Motofen, Lyrica, Parepectolin
It’s also more pure than it used to be. Even if you thought the war on drugs was a good idea, it’s pretty damning that most drugs have gotten both cheaper and more pure in the decades it’s been going on. This is according to the DEA’s own statistics, as well as plenty of others.
DEA is just following the regular rule change procedure. It's going to happen eventually.
I can't imagine bagholding weed stocks anymore. Donald Trump signed an EO to reschedule weed and the DEA told him to kick rocks. ByRon tried to reschedule. Somehow D8 is now more illegal than it used to be. The only thing getting smoked is my tendies.
Funny the DEA has time to approve some company to buy cocaine legally for “Research” 🧐 But can’t find the time to reschedule cannabis.
Executive Order is signed already, also RFK was literally there at the office thanking Trump for rescheduling cannabis. The HHS ranks leagues above the ONDCP in these matters, and in the end it's still the DOJ and DEA call. That's not happening. Also, >That’s why we reiterate our call that the director of ONDCP should be elevated to the Cabinet-level status the position once enjoyed: our drug crisis demands nothing less. That's on the same weblink posted here. All of this is beyond her power.
So....How long do you guys believe that Pam Bondi has left before kicks her out of the DOJ? I think she has a week left now. Now it makes a little more sense that Gaetz said it's the DEA that is drafting the final rule 😂 ...Oh God
Here is a list of pathways articulated, I am sure you've seen this already, but still sharing for awareness. https://www.jdsupra.com/legalnews/cannabis-in-2026-part-i-marijuana-1805293/#:~:text=On%20January%206%2C%202026%2C%20DEA,legislation%20enacted%20in%20late%202025)
He retired after November. He saw the writing on the wall. AG had yo intervene in the process to get DEA out of the way after the proposed rule making period ended, also. Law enforcement is inherently reactionary and conservative. That is why they do what they do, including postponing, sidelining, and outright denial of judicial review as they did in the case of MDMA scheduling.
its hard to speculate on why they did these things.......frame looks less as a political play and more as a timing/optics issue: the DEA may have simply expected the process to get less attention with a new president-elect in office. The HHS recommendation came about a year before the election, and then the ALJ retired, which naturally paused the formal process without implying any improper motive. ([cannabisbusinesstimes.com](https://www.cannabisbusinesstimes.com/cannabis-rescheduling/news/15751360/dea-judge-overseeing-cannabis-rescheduling-hearing-set-to-retire?utm_source=chatgpt.com))
I would argue they were never a block to the final outcome, but a delay by DEA until a presumably more advantageous presidency for them. I don't think it worked out that well, but the delay was clearly yo remove a policy win from Biden. I don't see the second statement anywhere in the second link, but whatever. It doesn't matter that much to me. We will all have to wait and see how it proceeds. I expect conservative groups to file a plethora of lawsuits after the final tule is published.
the ALJ paused the hearings in Jan 2025 pending an interlocutory appeal and then retired mid‑2025; no new ALJ has been publicly assigned, so the formal hearing phase remains stalled. ([cannabisbusinesstimes.com](https://www.cannabisbusinesstimes.com/cannabis-rescheduling/news/15751360/dea-judge-overseeing-cannabis-rescheduling-hearing-set-to-retire?utm_source=chatgpt.com)) That said, the December 18, 2025 Executive Order doesn’t nullify administrative process — it directs DOJ/HHS/DEA to finish the rulemaking “in the most expeditious manner permitted by law,” which means agencies can’t use the lack of an ALJ or other procedural pauses as an excuse to stall indefinitely. --------That phrasing does two things: (a) it makes completing the rulemaking an express White House priority, and (b) it reduces the cover agencies previously used to justify indefinite delays -------because further delay becomes an arguable failure to follow the President’s directive and can invite judicial/congressional enforcement. This gets into APA (Administrative Procedure Act)lawsuits ......([presidency.ucsb.edu](https://www.presidency.ucsb.edu/documents/white-house-fact-sheet-president-donald-j-trump-increasing-medical-marijuana-and?utm_source=chatgpt.com)) So yes, the administrative‑law mechanics still matter, but they’re now largely a timing issue rather than a blocker of the ultimate outcome. ([blankrome.com](https://www.blankrome.com/publications/hold-your-horses-cannabis-rescheduling-hearings-stayed-pending-appeal?utm_source=chatgpt.com))
There were ongoing hearings in the administrative law process, which may or may not be necessary to the process. There is likely going to any judge replacing the DEA judge in charge of this case. There are other judges, but no word of the hearings proceeding. You seemed to be speaking authoritatively about that process, and the state of the case. I wondered if you had any knowledge of the administrative law review moving forward or not. You seem to be under the impression that it is just a moot point under the EO, which grants "authority" in some weird way to DEA specifically to complete the process. I don't know enough about administrative law to know, and can admit that, which is why I asked. I understand it is a review of the process in most cases. To find out if the correct process was adhered to under the policy and statutes pertaining to the process. It is a checkbox that usually had to get checked in changing policy internally or deciding cases that would open the agency to litigation. I was wondering if you had followed whether or not the administrative law review actually was going to continue. Some people beleive there is a stay in place from the previous judge. But honestly I haven't looked into it. I am at the point where if it happens it happens.
>According to an advisor to President Trump, AG Bondi informed multiple people this week that the DEA will publish a final cannabis rescheduling order "in a matter of days". This means if the agency doesn't meet Trump's end-of-January directive, it likely won't be missed by much. [https://x.com/AMartinelliWA/status/2016996104022478925](https://x.com/AMartinelliWA/status/2016996104022478925) No one seems to believe it so we'll see what happens in the next few days/weeks
the executive order from Trump gives the DEA Administrator authority to move the rulemaking forward. So while the hearing is technically stalled, **the EO ensures Schedule III isn’t blocked — any delay now just affects timing, not the outcome**.
What happens to those hearings without any administrative law judge at DEA? I am pretty certain that the GOP is against the process of agency employed administrative law judges since they sued several times against the process for other agencies.
I don’t dispute that the DEA previously used procedure to delay.....the record supports that....... That’s exactly why the EO matters. It explicitly directs DOJ, HHS, and DEA to complete Schedule III rulemaking expeditiously and in coordination, which removes their ability to hide behind internal process indefinitely. They can still follow the law, but they can’t slow-walk it anymore. At this point, delay affects timing, not outcome. Schedule III is a when, not an if.
n a move that could significantly impact the [cannabis reform landscape](https://www.benzinga.com/topic/cannabis-reform?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=40567326), the **Drug Enforcement Administration** (DEA) announced a delay on Monday in the rescheduling of marijuana, noting it would hold an administrative hearing for December 2, which pushes any decision on the matter until after the [2024 election](https://www.benzinga.com/topic/2024-election?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=40567326). [https://finance.yahoo.com/news/dea-delays-cannabis-rescheduling-decision-022441964.html](https://finance.yahoo.com/news/dea-delays-cannabis-rescheduling-decision-022441964.html)
What does the DEA even do at the administrative, white collar level? Seems like they just do paperwork for Big Pharma to continue administering fentanyl and fentanyl derivatives. Do something else, guys.
Ah yes, DEA smash things fast, drag feet slow....... very great analysis. Meanwhile, real Schedule 3 rescheduling involves careful HHS review, decades of abuse potential studies, medical use evidence, and federal regulatory checks......not grunts or swings of a club. But sure, your one-sentence caveman wisdom totally explains bureaucracy!
Right, because clearly Milgram’s oral diplomacy is the real bottleneck in DEA Schedule 3 cannabis policy.........Meanwhile, the DEA and HHS are still doing the boring stuff...... analyzing pharmacology, abuse risk, and medical use....
The idea that agencies would ignore rescheduling is off-base. The process stalled under the last administration not because the DEA or HHS refused to act, but because of procedural hurdles and an administrative appeal. In early 2025, a hearing to evaluate reclassifying cannabis from Schedule I to Schedule III was paused due to an interlocutory appeal, and later the DEA’s chief Administrative Law Judge retired, leaving the case without a judge to preside. These delays are procedural, not a refusal to comply with the law. What’s different now is the executive order from Trump, which explicitly directs the DOJ, HHS, and DEA to complete the Schedule III rulemaking in the most expeditious manner in accordance with federal law. This restarts and accelerates the stalled process, and agencies cannot legally refuse to follow it. For U.S.-domiciled MSOs, the Schedule III catalyst remains very real.
Honestly, that sounds more like a conspiracy than reality. The HHS and DEA follow the law and the process set by the president and Congress. Schedule III rescheduling isn’t arbitrary — it goes through a formal statutory review. There’s no evidence that agencies refuse to comply; historically, these processes are slow but ultimately legal mandates are followed. For investors, the key takeaway is that if Schedule III is finalized, the structural upside for U.S.-domiciled MSOs is real. 280E taxes drop, cash flow jumps, and institutional investors can finally enter. Betting on regulatory non-compliance is much riskier than betting on the law actually being implemented.
“I have been told that the DEA is drafting this rule and moving it ASAP” I agree this means they are doing the heavy lifting (which could be argued was already done pre ALJ hearing by the dea), but I read this as they will aslo be the ones signing off on the final rule (since they are drafting it). But I do know your position is we are lightyears away from final rule and additional steps (like hiring AL judge is needed). Anyways, I hope we are both wrong and that DOJ will make the final rule over the next few weeks :)
You can’t really separate the two — federal medical use of CBD isn’t possible without a rescheduling step first. Any update alone, like FDA guidance or news, doesn’t change the fact that the DEA has to adjust the schedule. In practice, rescheduling and medical approval go hand in hand: one can’t happen without the other.
What Gaetz said was the DEA will do the heavy lifting before (not after) the final rule is issued.
Take it how you will, AI summary of DOJ v DES on final ruling. "The Department of Justice (DOJ), specifically the Attorney General, has the authority to issue the final order for cannabis rescheduling, though this power is generally delegated to the Drug Enforcement Administration (DEA). Following the December 18, 2025, Executive Order, the process is expected to move forward with the following roles: The Attorney General (DOJ): Under the Controlled Substances Act (CSA), the Attorney General is authorized to initiate and complete the rescheduling process. In the current effort, Attorney General Merrick Garland previously initiated the process, and recent actions indicate the DOJ will take final steps to move marijuana to Schedule III. The DEA: As an agency within the DOJ, the DEA is the operational body that handles the administrative record, reviews public comments, and conducts required hearings. While DEA officials have claimed "final authority" to determine scheduling, this authority is delegated from the Attorney General. Key Takeaways on the Final Order: Procedural Pathway: The DOJ may choose to issue a "Final Order" under the treaty exception (21 U.S.C. § 811(d)), which is faster, or finalize the pending rulemaking process (21 U.S.C. § 811). Final Action: Once the administrative process (including potential hearings and a 60-day review under the Congressional Review Act) is complete, the DEA/DOJ will publish a final rule in the Federal Register. Effective Date: The reclassification to Schedule III only becomes legally binding after the final rule is published and its effective date arrives. Despite the executive order to expedite, the process is not automatic and remains subject to required administrative steps and likely legal challenges.
I don’t fully understand. If DEA creates the final rule and in the federal register…that’s it. It is final. There are steps after that but nonthless I don’t see how those next steps are imapcted by the party that puts it into the federal register. I could easily he wrong, but I haven’t heard a solid argument yet how they could corrupt the case AFTER final rule is made
Nothing in this space makes Sense unfortunately but hope you are right. DEA crooked.
Hope so. I watched the latest TDR podcast this morning. Anthony wasn't confident that the DEA taking over the final rule was a positive thing. ( as per Matt Gaetz tweet ) I personally can't imagine that Trump would sign an EO and direct Bondi to do it as quickly as possible. Then list it as one of the top accomplishments of his 1st year. Only to have it handed to the DEA so they can impeed any future progress on S3. Doesn't make sense to me
There are several thousand administrative law judges in the executive branch. No one ever claimed that administrative law judges are unconstitutional. There have been constitutional challenges to their independence, not surprising in the Trump era. They are indispensable for many agencies (particularly SSA). I don’t think the DEA uses them often, so Bondi will have to assign one from another agency. It’s possible that Bondi is vetting a short list of them before she issues the assignment to finish the necessary work to get S3’s final rule promulgated. Taking her time and getting things right is more important in the long run.
So, if we assume that the next step is indeed "DEA to publish rescheduling order", I believe it would indicate no ALJ hearing. This seems in line with Shane Pennington's expectations from last year. https://x.com/admindotlaw/status/1962185325750390900?s=20
Matt Gaetz, re "Why hasn’t Pam Bondi finalized the rescheduling of marijuana. Thank you for your time. 🙏" : I have been told that the DEA is drafting this rule and moving it ASAP.
Last I heard my plug is cleaning $10k/month. I wouldn’t take that risk for 10x that. She deals with super sketchy people and she’s potentially she’s under an FBI/DEA watch. Best case scenario I got an “out”
For the ten thousandth time DEA or AG can make the call.
Milligram (and by extension the DEA) pulled all sorts of shenanigans under Biden. One note is that DJT has a very different leadership style.... I'm cautiously hopeful DJT pushes it through before midterms as we could see Dems double down with legalization as the new 🥕
Unfortunately this seems to be correct. Harris was a horrible choice to run against DJT. And while Harris was very pro cannabis.. Im not sure The DEA would have followed her direction anyway. (The DEA has the final say) I'm not 100% convinced the DEA will even follow Trumps direction... But the odds are better for sure.
How would they deal with a stay when DEA has no administrative law justices anymore?
Reasons why I think S3 won't happen before the end of february 1- Pam Bondi has to deal with the stay Mulrooney issued on the S3 hearing on January 13th 2025 because of claims that DEA and SAM were sleeping in the same bed 2- Even if we had a EO issued, Pam Bondi has to be surgical and find a balance with her power to accelerate the process while ensuring that the final rule is not vulnerable to lawsuits or legal shenanigans. With that being said, I am happy about my positions in CRON and GTBIF that I initiated 2 weeks ago and will continue to add as much as I can. I learned my lesson with MSOS badly managed basket and CGC red diluting machine
Yeah that seems to be the illogical yet commonly occurring answer. The DEA/ DOJ has proven multiple times that is does not want cannabis rescheduling to happen. So they will use any possible excuse to push it back. Have things changed now with DJT in power? So far no.
I'd go with adhd meds, diagnosis is rising, especially from women, there are frequent shortages, the amount of pills produced is limited by DEA, and people take them for life.
Eastern Europe bullish, DEA bearish, volatility priced in—still calls.
That gives me some hope. And while its very clear Trump calls the shots for the DOJ, Both the DOJ and DEA have proven time and time again how they can stifle progress. Without some renewed pressure from DJT were back to waiting.
CBD program update due 4/1, DEA Supply chain conference sometime that month (I can't find a date), and Friday news dump instead of Monday morning press rollout.
It’s the truth unfortunately. Nothing DEA or DOJ is quick.
I hope it’s soon because there is a lot of back and forth red tape. Hearings and such it’s not just that Pam b can reschedule it it has to go to DEA and could be blocked in court battles for awhile plus the public comment time and stuff.. I wish Trump would wave a wand and it is done, but it may be a bit longer before it’s a law.
Those DEA agents should've worn masks, now people are going to say they look like football players.
I see DEA grabbed him too.... probably because he was covered with the white stuff...
At which point, if the DEA approves it, it will then go through several months of hearings before ever potentially seeing the light of day.
Start with the question “who on weedstocks has lost the most?” Not in dollar terms, but percentage of net wealth, it has to the otm call option gamblers. If you look at their belief system, one thing from their posts stands out. They have always seemed to believe that there is no actual work involved in the process. Someone just needed to wake up one day and sign something. Let’s call them JSIAs (just sign it already). After Biden’s announcement in October 22, the JSIA crowd argued that S3 would be finished before the end of calendar 2022–thus ending 280e for that year’s books. And they played near-term, otm calls accordingly even when multiple people here and external legal experts explained that was impossible. Then, the attention turned to Anne Milgram, and “when is she going to sign off” threads became a daily occurrence. And they played otm call options accordingly even when long time posters with a scientific background told them that the “State of the Science” report would be a complex and contentious slog. Take a look back at the excellent work done by several experts who read every single page of the 250 page report posted along with the proposed rule. That report involved a lot of work by a bunch of very smart people. Remember also that the DEA didn’t sign the proposed rule. The DOJ signed off on it. Then, the alj had to specifically and pointedly ask the DEA lawyer: “Just to be clear, the DEA is a proponent of it’s own proposed rule. Right?” If the DOJ and DEA are going to follow Trump’s order to finish the process, they have a lot of difficult work ahead. If nothing else, they have to put together a document which answers public comment period challenges.
Ran this video plus the interview with Shane Pennington through some LLMs. **Looks like we have Two Paths Forward** To reach Schedule III, the Attorney General (AG) must choose between two procedural paths. **Path A: The Standard Administrative Path (Slow)** If the AG follows standard procedure to minimize appeal risks, the timeline drags out significantly. 1. **Resolve Appeal:** The DEA Administrator must rule on the pending interlocutory appeal (Timeline: 1–12 months). 2. **Appoint Judges:** The DEA must hire or borrow ALJs to preside over the case (Timeline: Months). 3. **Evidentiary Hearing:** A formal hearing on the merits is held (Timeline: Months). 4. **ALJ Report:** The judge issues a recommended decision (30–90 days). 5. **Final Rule:** The AG reviews the record and publishes the rule. • **Estimated Arrival:** Late 2026, 2027, or drifting into 2028. **Path B: The "Accelerated" Path (Expeditious)** This is the path implied by the Executive Order and expected by industry insiders to meet a near-term deadline. 1. **Bypass Hearing:** The AG could withdraw the hearing order or utilize the "Treaty Exception" (21 U.S.C. 811(d)), citing the 43,000+ comments and HHS scientific findings as a sufficient record. 2. **Issue Final Order:** The AG signs the Final Rule immediately, mooting the pending appeal. • **Estimated Arrival:** **February 2026**.
Uh, uh, B.I.G., P O, P P A, no info, for the, DEA Federal agents mad cause I'm flagrant Tap my cell and the phone in the basement
So if we get a huge pop when the DEA final rule hits, sell, and buy back in during the freeze out in the house? Got it.
Found this on linkedin yesterday. >Policymakers and regulatory agencies must consider pathways that retain essential safety oversight while reducing redundant barriers to research. While DEA rescheduling to Schedule III may alleviate certain administrative and tax-related constraints, it does not, on its own, resolve the FDA, IRB, state-level, and manufacturing barriers that uniquely burden investigator-initiated cannabis research. For example, harmonizing DEA and state licensing requirements, reconsidering cannabis scheduling, expanding access to research-grade cannabis products (including isolates of naturally occurring and semi-synthetic THC-isomers currently not included in the NIDA Drug Supply Program), permitting the use of commercially available cannabis products authorized for sale under state regulatory frameworks, and modernizing the IND process for cannabinoids could dramatically lower the entry threshold for conducting meaningful human research. Until such reforms are implemented, a persistent gap will remain between widespread cannabis use and rigorously designed human research, reflecting the relative scarcity of controlled clinical studies needed to understand its health effects. https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.70195
But not with the DEA. Wait…, yup he might
Must be cocaine bear since the DEA is involved.
I could've sworn this founded familiar and confirmed that this has been happening since Sept 2024 and is not a new development. There's an MM article about this from Sept 2024 titled "DEA Acknowledges New Two-Step Test For Marijuana’s Accepted Medical Use Is Legitimate"
One of the rumoured dates of a ruling from DEA. I'm skeptical but monitoring.
I do not support CIA,DEA or drug enforcement due to their cooperation with Cartels for profiting. I have been involved with Mexican Americans for most my life and have known many who laundered money for the cartels and ran drugs over the border. They did fine without any American intervention. Urban areas where young people sell drugs in parks high schools and bars are not supervised by boomers. So educate yourself to the fact the Mexican songs called Narcocorridos. Funny how reddit has so many experts with bad googled facts. Young and dumb is a thang.
No one knows how cannabis will be regulated under schedule 3. Add in still-federally illegal recreational cannabis and it becomes even more confusing, especially for MSOs in the recreational space. Schedule 3 drugs can be imported into the United States with permission from the DEA and proper permits, registration, etc. Will cannabis be any different? Wait and see.
No, now it's just career functionaries at the DEA/DOJ resisting change.
Tim Apple has been apprehended by the DEA following a surgical military strike.
You clearly hate Trump and don't have any sense of reality here. This administration has been focused on rescheduling for a while. When the new DEA head was sworn in, he said this was one of their top priorities. That was many months ago. You can bury your head in the sand and ignore everything, but don't expect me to believe your clearly biased spin on the facts.
Thats actually a real ETF. Due to the government reduction in staffing and building leases it would probably be better to go with puts. Easterly Government Properties ETF ticker DEA.
imagine not being a tall chad dictator, taking selfies with DEA agents and probably get deported back by ICE what a time to live
That's the concern. If the DOJ waits on the DEA.. we've seen this play out already.
DOJ movement, DEA isn't gonna do shit at this point.
I'm a bit baffled myself. I think were stuck in this pattern till we see some DEA/DOJ movement. Or worse we see some DEA slowwalk shenanigans again.
Maduro and his wife had 3 DEA agents for his perp walk while Luigi had an entire football team with automatic rifles lol.
Zero. The process is still pending until the DOJ decides to enact on it. DEA has made it clear so far that they won't do anything with, it's up to Pam Bondi now.
Any worries about the MJMoment article where the DEA is saying that rescheduling is still considered “pending” despite the executive order?
Find you a girl that smiles at you like Maduro smiles when he’s with the DEA
DEA agents look out of shape. Is that why special forces did most of the work?
Wow these are real pics DEA agents are actually posing with Nicolas Maduro Ngl I thought they were AI generated
War on drugs was really about the oil 🥭 renaming DEA
Why was Maduro wearing Mickey ears when brought to the DEA office
Oil is what everyone is talking about, but there are three other major parts of the story that no one has mentioned. First, minerals: the Orinoco region is one of the areas with massive concentrations of coltan, a critical component for electronic goods. Second, drug corridors used to move cocaine to Europe and Asia via Africa, which represent one of the largest revenue sources for the DEA—if they bother to intercept it. Third, human trafficking tied to illegal mining, drug mules, logging, and prostitution. These activities represent billions of dollars in the hands of criminal organizations that could not care less about what just happened and that will spread instability across the region. This may be part of a long-term strategy by the American military-industrial complex to consolidate more power. I think this is only the beginning.
I was talking about the DEA specifically. Why is the drugs agency kidnapping foreign heads of states? I was told that Maduro was a dick but I didn’t know that Venezuala was governed by a cartel. That’s why they are clowns
I believe the DEA is the agency prosecuting him with assistance from the US military.He is already in Ny. Same place as el chapo. I think they changed his clothes out of the gray sweats once he arrived
Maduro is a big dude but only listed at 6’3. Are all these DEA agents like dw*rves?
Lmao ok so a few posts here and there with minimal supporting comments about the subject... Does that mean "this sub is convinced Trump will legalize cannabis"? Regarded as I said. As for progress... Trump signed an executive order to get things moving... Why did Biden's AG and DEA stall for 2 years? Do you not remember ?[ALJ calling them out](https://x.com/JoeCool_15/status/2007137236257759406)
But he was wearing a dress shirt and jacket in the captured Pic by DEA.🧐
Does that matter though when fentanyl isn't coming from Venezuela? The DEA website says so itself.
The next step would be the DEA making a determination and the DOJ handing it over to the WH to sign off on. There is also some review period baked in iirc.
Happy new year! 1. schedule 3 finalized please 2. Uplisting 3. Safe/safer 4. Florida rec 5. DEA and crooked desantis get sued 6. Recoup of 280e tax overpayments please Thanks and best wishes to all cannabis investors that are long
I would imagine the DEA's top priority is protecting their budget.
I agree with this. The pro cannabis people should say the recommendation to move to schedule 3 was 2.5 years ago. That’s more than enough time. Now fuck off and move to final rule already. it’s obviously because the ‘against‘ proponents of change are fighting tooth and nail to stop this like the crooked DEA. I hope the mso’s sue the dea after this is over as they stopped them from realizing 2023 and 2024 tax overpayments. i really hate that the dea got away with this crap.
So you expect a DOJ/DEA administration that is vehemently against rescheduling, during a time when more and more conservatives are defying POTUS, to just.....knock this out in less than a month without dragging their feet? You expect a congress/house full of GOP members who are against marijuana use entirely, during a time when more and more senators/legislators are defying trump to just pass SAFER now despite it having been around for a DECADE? You expect democrats to suddenly give up all the equity components of any legislation to pass SAFER (which would be required to get any GOP legislators on board)? You expect the stock market, a traditionally cautious and risk averse entity when evaluated as a whole, to embrace one of the more polarizing topics of the last few decades, mere months after one of the most fickle and capricious POTUS pushed for it to happen? You expect adult use to pass in florida a mere 2 years after it failed last time, where it's already facing massive hurdles due to signature invalidations and smear campaigns from DeSatan? Look, I'm long on this industry as well. I'm hoping/counting on my Trulieve stake alone to pay off my mortgage in a handful of years. But it's a pipe dream to think the above things will happen soon, and more so to think all of them will happen within the next year. DOJ/DEA is STILL taking a hard stance against Marijuana and spoken out against S3. Bondi (who echoed dislike for Marijuana under DeSantis) was not at the signing. They defied Biden when it was ordered. More and more administrators are ignoring trump. I don't think this will happen in the next month or two and I actually don't think it's a sure bet to happen at all (Trump's health is not great. Who's to say the old fuck doesn't croak and then nothing happens) SAFER has been on the books for a decade. Democrats won't push stuff up unless it has equity concessions. A lot of GOP don't like marijuana legislation at all. This has an uphill battle. Uplisting is in the same boat as SAFER. SAFER passes, it will definitely happen. But I don't think it will be fast. Uplisting has stringent requirements and companies FRESHLY "Not loosing 100M a year in taxes" may be an uphill battle as well. Florida Rec.... Ugh. It narrowly failed in 2024. It COULD have (could still) conceivably pass with the bill issues resolved from last year and better marketing campaigns. But smart and safe fucked up the signature sheets and didnt have the full text of the bill listed. Now with 270k -ish signatures invalidated, it's looking very uncertain. Yes, they are suing the state. But the state's courts are also conservative and it could honestly go either direction.
Market manipulator **Doug Kass** in May 2024 (20 months ago) hyping DEA approval. **What’s the latest with this charlatan?** Article quoting **Doug Kass** on cannabis rescheduling: Reform: Our Industry’s Great Divide — MJ Magazine — This article quotes Kass’s post on X that said: **”We have learned yesterday that the U.S. Drug Enforcement Administration will shortly approve a rescheduling of cannabis to Schedule III…”** according to his social-media posts. https://mgmagazine.com/business/legal-politics/reform-our-industrys-great-divide/
This argument is very interesting. It’s hard to see how rescheduling satisfies any treaty obligations though. In the early days, treaty obligations were viewed as a potential bar to rescheduling. And Trump ordered his people to restart the rule making process under the CSA, not find a circumvention of the process. I’m also not sure “can satisfy” is the appropriate language. “Must be done to satisfy a treaty obligation” is more likely the right test. I hope you’re right. If so, the first step will be something about making a request to the legal counsel’s office. If I’m right, it will be the appointment of a new ALJ or a publication of the DEA’s responses to public comments.
We agree on the main point: S3’s effect on our companies is not recognized and priced in. I disagree about the probability of legislative liberalizations following behind that. We also disagree about how much uplisting matters for price discovery. Our biggest area of disagreement is on what needs to be done to reach the goal. It’s been a common belief on this board—going way back to the process to get to the proposed rule starting back in 23–that someone could just wake up one morning and sign something that actualized S3. The rule making process is carefully laid out in the CSA. The head of the DOJ or DEA can’t just sign something that puts S3 into effect. Trump’s executive order directly instructs the DOJ and DEA to “complete the rule making process.” To get to the proposed rule, FDA experts had to put together a 250 page report on the state of the science. Each step of the rule making procedure needs to be followed. For example, as part of the rule making process the DEA needs to address all the comments in the public comment period. That document requires careful and thorough documentation to pass muster with the inevitable challenges made by opponents.
If that is their path there will be a new DEA Chief and personnel. And a new AG if she's involved imo. Garland should have been fired along with the DEA entrenched obstructionists. imo Trump is trying to find out what is going on by pressuring the DEA/DOJ with the EO if continue delays.
For the record, S3 is not "done". It is still with the DEA. All Trump did was tell Bondi to make a decision, with no concrete timeline or even an end result.
Should have fired those S3 DEA/DOJ obstructionists years ago. Butnhere we still are.
Under the Controlled Substances Act, the authority to reschedule substances via the executive branch belongs to the AG. Historically the AG has delegated it to the head of the DEA, but they are not obligated to do this. Source: https://www.congress.gov/crs-product/R45948#fn84 If you believe Bondi does whatever Trump says (I do), then S3 is very likely to happen. Great time to buy!
S3 is not done. It’s at the same place it was during the Biden administration, waiting on the DEA to make a decision.